help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ValÍn, A.
Right arrow Articles by Esbrit, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ValÍn, A.
Right arrow Articles by Esbrit, P.
Endocrinology Vol. 142, No. 7 2752-2759
Copyright © 2001 by The Endocrine Society


ARTICLES

C-Terminal Parathyroid Hormone-Related Protein (PTHrP) (107–139) Stimulates Intracellular Ca2+ through a Receptor Different from the Type 1 PTH/PTHrP Receptor in Osteoblastic Osteosarcoma UMR 106 Cells1

Alvaro ValÍn, Carlos Guillén and Pedro Esbrit

Bone and Mineral Metabolism Laboratory, Research Unit, Fundación Jiménez Díaz, 28040 Madrid, Spain

Address all correspondence and requests for reprints to: P. Esbrit, Ph.D., Bone and Mineral Metabolism Laboratory, Research Unit, Fundación Jiménez Díaz, Avda. Reyes Católicos 2, 28040 Madrid, Spain. E-mail: pesbrit{at}fjd.es

Studies were undertaken to determine whether PTH-related protein (PTHrP) (107–139) mobilizes [Ca2+]i in osteoblastic osteosarcoma UMR 106 cells. PTHrP (107–139), in a manner similar to PTHrP (107–111), induced a rapid [Ca2+]i response in these cells that was dose dependent (EC50 of {approx}0.1 pM) and more efficient than that of PTHrP (1–36) (EC50 of {approx} 1 nM). This effect of PTHrP (107–139) was abrogated by micromolar doses of verapamil or nifedipine. However, it was unaffected by 10 µM U73122 (a phospholipase C inhibitor), 100 µg/ml heparin (an inositol 1,4,5-trisphosphate receptor inhibitor), or 400 ng/ml pertussis toxin (a Gi inhibitor), which inhibited the [Ca2+]i response to PTHrP (1–36), or by either 25 nM bisindolylmaleimide I (BIM), a protein kinase (PK) C inhibitor, or 1 µM phorbol-12-myristate-13-acetate preincubation (22 h). PTHrP (107–139) and PTHrP (1–36), at 100 nM, desensitized the [Ca2+]i response to a second challenge with the same peptide, but not with the other peptide in these cells. PTHrP (7–34), a type 1 PTH/PTHrP receptor (PTH1R) antagonist, decreased the effect of PTHrP (1–36) on [Ca2+]i. In contrast, PTHrP (107–111), but neither PTHrP (109–138) nor PTHrP (7–34), abolished this effect of PTHrP (107–139). Both PTHrP (107–139) and PTHrP (1–36), added together at submaximal doses, induced a higher [Ca2+]i response. Moreover, PTHrP (107–139) increased the efficacy of PTHrP (1–36) on [Ca2+]i, but decreased its induced increase in PKA activity in these cells. Verapamil or nifedipine (at 50 µM) or 25 nM BIM, but not 25 µM adenosine 3',5'-cyclic monophosphorothioate, Rp-isomer, a PKA inhibitor, abolished the PTHrP (107–139)-induced increase in interleukin 6 messenger RNA (assessed by RT, followed by PCR) in UMR 106 cells. This peptide also increased c-fos messenger RNA in these cells; an effect inhibited by BIM, but unaffected by either verapamil or EGTA. These findings support the existence of high-affinity receptors for PTHrP (107–139), associated with an induced Ca2+ influx, different from the PTH1R in UMR 106 cells. The present results suggest that PTHrP could affect bone turnover by interacting with the PTH1R and other yet unknown receptors in bone cells through complex mechanisms.




This article has been cited by other articles:


Home page
JDRHome page
G.E. Wise, Y. Ren, and S. Yao
Regulation of Osteoprotegerin Gene Expression in Dental Follicle Cells
Journal of Dental Research, April 1, 2003; 82(4): 298 - 302.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Li, R. L. Duncan, D. B. Burr, V. H. Gattone, and C. H. Turner
Parathyroid Hormone Enhances Mechanically Induced Bone Formation, Possibly Involving L-Type Voltage-Sensitive Calcium Channels
Endocrinology, April 1, 2003; 144(4): 1226 - 1233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guillen, P. Martinez, A. R. de Gortazar, M. E. Martinez, and P. Esbrit
Both N- and C-terminal Domains of Parathyroid Hormone-related Protein Increase Interleukin-6 by Nuclear Factor-kappa B Activation in Osteoblastic Cells
J. Biol. Chem., July 26, 2002; 277(31): 28109 - 28117.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society